Search

Search Results

• 

  Influenza vaccination is safe and effective in patients suffering from fibromyalgia syndrome

  J. N. Ablin, V. Aloush, A. Brill, M. Berman, M. Barzilai, D. Caspi, M. Mandelboim, D. Levartovsky, A. Polachek, Y. Wolman, D. Paran, M. Barkagan, O. Elkayam

  57-61

  16-09-2015

  https://doi.org/10.4081/reumatismo.2015.823

  2290

  PDF: 1071
• 

  Adherence to vaccination against SARS-CoV-2 and vaccine safety in patients with IgG4-related disease

  Linda Mastromanno, Federico Giardina, Angelica Gattamelata, Serena Colafrancesco, Simona Truglia, Francesca Romana Spinelli, Edoardo Simoncelli, Bruno Lucchino, Fabrizio Conti, Roberta Priori

  22-01-2025

  https://doi.org/10.4081/reumatismo.2025.1744

  1361

  PDF: 110

  SUPPLEMENTARY MATERIAL: 40
• 

  Idiopathic inflammatory myopathies linked to vaccination against SARS-CoV-2: a systematic review

  A. Camargo-Coronel, H. Quiñones-Moya; M.R. Hernández-Zavala; J.R. Hernández-Vázquez, M.Á. Vázquez-Zaragoza

  08-05-2023

  https://doi.org/10.4081/reumatismo.2023.1548

  2020

  PDF: 1430
• 

  Disseminated cutaneous herpes simplex infection after COVID-19 vaccination in a rheumatoid arthritis patient: a case report and review

  D. Mohamadzadeh, S. Assar, M. Pournazari, P. Soufivand, S. Danaei

  13-09-2022

  https://doi.org/10.4081/reumatismo.2022.1489

  1797

  PDF: 1049
• 

  Erythema nodosum after COVID-19 vaccine

  B. Maranini, G. Ciancio, M. Corazza, F. Ruffilli, G. Galoppini, M. Govoni

  03-05-2022

  https://doi.org/10.4081/reumatismo.2022.1475

  2738

  PDF: 1101
• 

  Vaccination of mice for research purpose: alum is as effective as and safer than complete Freund adjuvant

  N. Bassi, R. Luisetto, A. Ghirardello, M. Gatto, B. Bottazzi, Y. Shoenfeld, L. Punzi, A. Doria

  380-387

  20-12-2012

  https://doi.org/10.4081/reumatismo.2012.380

  2414

  PDF: 1000
• 

  Myositis after SARS-CoV-2 vaccination occurs more frequently than assumed and is probably causally related

  J. Finsterer, A.S. MohanaSundaram, F. Scorza

  18-09-2023

  https://doi.org/10.4081/reumatismo.2023.1601

  1298

  PDF: 459
• 

  Response to: myositis after SARS-CoV-2 vaccination occurs more frequently than assumed and is probably causally related

  H. Quiñones-Moya, A. Camargo-Coronel, M.R. Hernández-Zavala

  18-09-2023

  https://doi.org/10.4081/reumatismo.2023.1623

  962

  PDF: 324
• 

  Patients with systemic lupus erythematosus and their experience with vaccination against COVID-19: a descriptive and explanatory study

  F. Ceccarelli, V. Covelli, G. Olivieri, F. Natalucci, C. Alessandri, F. Conti

  13-09-2022

  https://doi.org/10.4081/reumatismo.2022.1491

  1165

  PDF: 568
• 

  Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab

  J. Finsterer

  03-05-2022

  https://doi.org/10.4081/reumatismo.2022.1474

  2018

  PDF: 546
• 

  Reply to: “Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab” by Josef Finsterer

  B. Maranini, G. Ciancio, R. Cultrera, M. Govoni

  03-05-2022

  https://doi.org/10.4081/reumatismo.2022.1482

  2252

  PDF: 628
• 

  Comment to: Disseminated cutaneous herpes simplex, COVID-19 vaccination and rheumatoid arthritis patient: a case report and review

  B. Joob, V. Wiwanitkit

  29-12-2022

  https://doi.org/10.4081/reumatismo.2022.1527

  812

  PDF: 355